Fortress Biotech Inc (FBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -103,408 | -49,478 | -164,826 | -96,318 | -50,457 |
| Depreciation Amortization | 5,364 | 2,585 | 10,705 | 6,733 | 4,277 |
| Accounts receivable | -5,514 | -7,995 | 768 | -7,743 | -2,208 |
| Other Working Capital | -1,461 | -5,658 | 36,373 | 20,156 | -2,874 |
| Other Operating Activity | 16,735 | 13,686 | 440 | -672 | -4,886 |
| Operating Cash Flow | $-88,284 | $-46,860 | $-116,540 | $-77,844 | $-56,148 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,644 | -1,337 | -15,946 | -12,439 | -4,898 |
| Net Acquisitions | -20,000 | -20,000 | N/A | N/A | N/A |
| Purchase Sale Intangibles | N/A | N/A | -400 | -400 | -400 |
| Other Investing Activity | 0 | 0 | 56,460 | -400 | -400 |
| Investing Cash Flow | $-21,644 | $-21,337 | $40,514 | $-12,839 | $-5,298 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 7,000 | N/A | N/A |
| Debt Issued | 42,112 | 42,129 | N/A | N/A | N/A |
| Debt Repayment | N/A | N/A | -10,450 | N/A | N/A |
| Common Stock Issued | 5,853 | 116 | 9,679 | 453 | 302 |
| Common Stock Repurchased | -1,698 | -1,698 | N/A | N/A | N/A |
| Dividend Paid | -4,391 | -2,195 | -8,780 | -6,585 | -4,390 |
| Other Financing Activity | 11,079 | 11,612 | 151,545 | 116,185 | 107,175 |
| Financing Cash Flow | $52,955 | $49,964 | $148,994 | $110,053 | $103,087 |
| Beginning Cash Position | 307,964 | 307,964 | 234,996 | 234,996 | 234,996 |
| End Cash Position | 250,991 | 289,731 | 307,964 | 254,366 | 276,637 |
| Net Cash Flow | $-56,973 | $-18,233 | $72,968 | $19,370 | $41,641 |
| Free Cash Flow | |||||
| Operating Cash Flow | -88,284 | -46,860 | -116,540 | -77,844 | -56,148 |
| Capital Expenditure | -1,644 | -1,337 | -15,946 | -12,439 | -4,898 |
| Free Cash Flow | -89,928 | -48,197 | -132,486 | -90,283 | -61,046 |